HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Inducing Immune Quiescence to Prevent HIV Infection in Women [NA]
Clinical trial completed test of inducing immune quiescence to prevent HIV infection in women; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis [Phase 2]
Phase 2 study evaluating simtuzumab in adults with liver fibrosis and hepatitis C, including HIV co-infection; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children [Phase 3]
Phase 3 trial update evaluating bronchopulmonary function response to azithromycin in chronic lung disease associated with HIV infection in …
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: The Health Access and Recovery Peer Program [NA]
Clinical trial update for the Health Access and Recovery Peer Program; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART [Phase 4]
Phase 4 clinical trial evaluating ER Niacin/Laropiprant impact on cardiovascular markers and atheroprogression in HIV-infected individuals o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-07FDA Approved: LAMIVUDINE — Supplemental Application (Ingenus Pharmaceuticals, LLC)
FDA approved a supplemental application for lamivudine from Ingenus Pharmaceuticals, LLC, confirming authorization for a lamivudine product …
-
FDA approval · 2019-10-03FDA Approved: LAMIVUDINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp.'s lamivudine, expanding access to a generic lamivudine product.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria [Phase 4]
Phase 4 trial assessing the impact of cotrimoxazole use in immunocompetent HIV patients on carriage of antimicrobial-resistant bacteria.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: HIV Adherence Bottle Intervention Trial [NA]
A completed clinical trial evaluating an adherence bottle intervention for people living with HIV-1 infection; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851) [Phase 4]
Phase 4 clinical trial assessing safety, tolerability, and pharmacokinetics of HIV integrase inhibitor raltegravir in healthy Japanese male …
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers [Phase 2]
Phase 2 dose-ranging study evaluating safety and immunogenicity of HIV vaccine 732461 in healthy HIV-seronegative volunteers completed.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: A Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-HIV Treatment [Phase 2]
Phase 2 safety and dose-exploration trial of Azvudine tablets in treatment-naïve patients with AIDS has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.
Clinical trial update reporting completed study on dual therapy with raltegravir and darunavir/ritonavir in HIV-infected patients, with resu…
-
FDA approval · 2019-09-26FDA Approved: LAMIVUDINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for lamivudine from Aurobindo Pharma Limited. This action relates to the approval of a supplemen…
-
FDA approval · 2019-09-26FDA Approved: LAMIVUDINE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Lamivudine from Strides Pharma Science Limited (ANDA 090457). This action confirms approval of a…
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Research In Viral Eradication of HIV Reservoirs [Phase 2]
Phase 2 clinical trial update on strategies to eradicate HIV reservoirs; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Analytical Treatment Interruption in HIV Positive Patients [NA]
Clinical trial update on analytical treatment interruption in HIV-1 infected patients; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating autologous T-cells genetically modified at the CCR5 gene using zinc finger nucleases in HIV-infected s…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Treatment of PD-1 Inhibitor in AIDS-associated PML [Phase 2]
Phase 2 clinical trial evaluating a PD-1 inhibitor for AIDS-associated Progressive Multifocal Leukoencephalopathy (PML).
-
FDA approval · 2019-09-19FDA Approved: PIFELTRO — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for PIFELTRO (doravirine) by Merck Sharp & Dohme LLC.
-
FDA approval · 2019-09-19FDA Approved: DELSTRIGO — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) from Merck Sharp & Dohme LLC…
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis [Phase 2]
Phase 2 trial evaluating telmisartan added to ART during acute HIV infection to reduce CNS reservoirs and lymph node fibrosis; study complet…
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Drug Exposure Registry for GSK2248761, an Investigational NNRTI
A completed clinical trial registry update for an investigational NNRTI (GSK2248761) exploring drug exposure in HIV infections; results post…
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Acupuncture/Moxibustion for Peripheral Neuropathy in HIV [Phase 2]
Phase 2 trial update on acupuncture/moxibustion for peripheral neuropathy in HIV patients.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System [Phase 2]
Phase 2 trial evaluating GanedenBC30 (a probiotic) on the immune system in HIV infection and related GI symptoms; study completed with poste…